Kasey Raetz, Pharm.D., transitioned from working at a small independent pharmacy to leading product and pharma contracting strategy at Express Scripts, earning a PBMI Innovator Award for her creative ...

Trump has unveiled a number of moves aimed at cutting drug prices in recent months, but he has yet to move the needle on ...

In the final part of his Pharma Commerce video interview, Philip Sclafani, PwC's pharmaceutical and life sciences lead, ...

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...

WeightWatchers is now only offering Wegovy while other telehealth providers defiantly hang on to compounded alternatives.

Analysts are estimating that Liquidia will report an earnings per share (EPS) of $-0.41. The market awaits Liquidia's announcement, with hopes high for news of surpassing estimates and providing ...

The global Health Care industry has steeply underperformed regional equity indices over the last two years and notably since ...

Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...

Plus more pharma news from the Pharmalittle newsletter.

This episode of Pharma Pulse explores the FDA’s new proactive quality review initiative for drug manufacturing, GSK’s $370 ...

Some of Philadelphia’s biotechnology companies that specialize in cell therapy shed employees in recent weeks as the industry is facing some unique headwinds.

But the company would have to stall the profit drag from declines in volume for happoshu and new genre. Kirin’s strength in ready-to-drink spirits could help offset the decline in beer volumes. Kirin ...